Stephan Schann Selected Research

5-HT2B Serotonin Receptor

12/2021

Evaluation of a 5-HT2B receptor agonist in a murine model of amyotrophic lateral sclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stephan Schann Research Topics

Disease

2	Catalepsy 10/2017 - 09/2008
2	Parkinson Disease (Parkinson's Disease) 10/2017 - 09/2008
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 12/2021
1	Hypertension (High Blood Pressure) 01/2015
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2015
1	Mental Disorders (Mental Disorder) 01/2015
1	Sleep Wake Disorders 01/2015

Drug/Important Bio-Agent (IBA)

2	Haloperidol (Haldol)FDA LinkGeneric 10/2017 - 09/2008
1	5-HT2B Serotonin ReceptorIBA 12/2021
1	Oxidopamine (6 Hydroxydopamine)IBA 10/2017
1	metabotropic glutamate receptor 4IBA 10/2017
1	imidazoline I1 receptorsIBA 01/2015
1	LigandsIBA 01/2015
1	(3- chloro- 2- methylphenyl)- (4- methyl- 4,5- dihydro- 3H- pyrrol- 2- yl)amineIBA 01/2015
1	Biological ProductsIBA 01/2015
1	Pharmaceutical PreparationsIBA 01/2015
1	ProdrugsIBA 01/2015
1	Adenosine A2 Receptor AntagonistsIBA 09/2008
1	Adenosine (Adenocard)FDA LinkGeneric 09/2008
1	Dopamine Agents (Dopaminergic Agents)IBA 09/2008
1	Glutamic Acid (Glutamate)FDA Link 09/2008
1	1-aminocyclopentane-1,3,4-tricarboxylic acidIBA 09/2008